roxadustat - dofaq.co
Setahun Usai Didakwa Doping, Simona Halep Siap Banding Usai Diskorsing Empat Tahun | Korankaltim.com
Koran Kaltim - 25 Oct 2023
Setahun Usai Didakwa Doping, Simona Halep Siap Banding Usai Diskorsing Empat Tahun | Korankaltim.com ...
Mantan petenis No.1 Halep bertekad pulihkan nama setelah sanksi doping
ANTARA - 22 Oct 2022
Mantan petenis No.1 Halep bertekad pulihkan nama setelah sanksi doping ...
A nomogram for predicting the risk of treatment failure of roxadustat in peritoneal dialysis with renal anemia | Scientific ...
Nature - 01 Apr 2024
A nomogram for predicting the risk of treatment failure of roxadustat in peritoneal dialysis with renal anemia | Scientific ... ...
AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure
Fierce Pharma - 27 Feb 2024
AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure ...
FDA declines to approve FibroGen's roxadustat for anaemia of CKD
Pharmaceutical Technology - 29 Nov 2022
FDA declines to approve FibroGen's roxadustat for anaemia of CKD ...
Roxadustat Linked to Improved Iron Metabolism vs ESAs in Peritoneal Dialysis
HCPLive - 28 Nov 2023
Roxadustat Linked to Improved Iron Metabolism vs ESAs in Peritoneal Dialysis ...
AstraZeneca Returns to FibroGen the Rights to Roxadustat in US, Other Territories
BioSpace - 28 Feb 2024
AstraZeneca Returns to FibroGen the Rights to Roxadustat in US, Other Territories ...
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD
ScienceDirect.com - 17 Apr 2021
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD ...
Roxadustat Misses Mark as Anemia Treatment in Transfusion-Dependent, Lower-risk MDS
OncLive - 05 May 2023
Roxadustat Misses Mark as Anemia Treatment in Transfusion-Dependent, Lower-risk MDS ...
Roxadustat a new option for CKD-related anaemia | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
MIMS - 27 Jun 2020
Roxadustat a new option for CKD-related anaemia | Latest news for Doctors, Nurses and Pharmacists | Pharmacy ...
Roxadustat: Battle against doping faces new foe | Daily Sabah
Daily Sabah - 21 Jul 2023
Roxadustat: Battle against doping faces new foe | Daily Sabah ...
FibroGen scores Phase III win in China for roxadustat
Clinical Trials Arena - 18 May 2023
FibroGen scores Phase III win in China for roxadustat ...
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk ...
Yahoo Finance - 09 Dec 2023
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk ... ...
HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by ...
Nature - 08 Oct 2022
HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by ... ...
Chinese Phase 3 Trial of Roxadustat in Non-Myeloid Malignancies Meets Primary End Point
OncLive - 18 May 2023
Chinese Phase 3 Trial of Roxadustat in Non-Myeloid Malignancies Meets Primary End Point ...
Isolation, identification, structural elucidation, and toxicity prediction using (Q)-SAR models of two degradants: AQbD ...
ScienceDirect.com - 26 Apr 2023
Isolation, identification, structural elucidation, and toxicity prediction using (Q)-SAR models of two degradants: AQbD ... ...
FibroGen's AZ deal in danger after anemia drug fails in 2nd act
Fierce Pharma - 05 May 2023
FibroGen's AZ deal in danger after anemia drug fails in 2nd act ...
Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis ...
Nature - 18 Sep 2023
Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis ... ...
Surprise, surprise: AstraZeneca and FibroGen's once-hyped anemia drug roxadustat hits an FDA wall
Fierce Pharma - 11 Aug 2021
Surprise, surprise: AstraZeneca and FibroGen's once-hyped anemia drug roxadustat hits an FDA wall ...